Confronting Antimicrobial Resistance: Safeguarding our Medicines for the Future
This platform curates evidence-based insights, expert perspectives, and practical resources to support India’s response to antimicrobial resistance.
Why Antimicrobial Resistance Matters in India?
AMR is a growing public health challenge in India, making infections harder to treat and increasing risks in routine medical care. Addressing AMR requires timely diagnostics, responsible antimicrobial use, and coordinated action across health systems.
SMARRT Diagnostics: The Critical Enabler
Rapid diagnostics are a critical enabler of rational antimicrobial use. However, their impact is maximised only when combined with strong antimicrobial stewardship, trained clinicians, functional laboratories, and effective infection prevention and control systems.
S – Safe: Enables appropriate diagnostic consumption and protects healthcare workers.
M – Mobile: Reaches community settings, which are not just places of consumption but active sources of infection.
A – Affordable: Investing in accessible diagnostic tools is essential for India’s healthcare economics.
R – Rapid: Moves clinicians from empirical therapy to diagnostic-driven treatment.
R – Reliable: Provides high-accuracy resistance profiles to ensure evidence-based care.
T – Transparent: Ensures data clarity for local and national surveillance.
T – Transferable: Scalable impact when integrated with functional laboratories.